These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33125340)

  • 101. EphA2, vascular endothelial growth factor, and vascular endothelial growth factor correlate with adverse outcomes and poor survival in patients with glioma.
    Shen L; Sun R; Kan S; Wang Z; Yu Z
    Medicine (Baltimore); 2021 Jan; 100(3):e23985. PubMed ID: 33545987
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Radiomics can differentiate high-grade glioma from brain metastasis: a systematic review and meta-analysis.
    Li Y; Liu Y; Liang Y; Wei R; Zhang W; Yao W; Luo S; Pang X; Wang Y; Jiang X; Lai S; Yang R
    Eur Radiol; 2022 Nov; 32(11):8039-8051. PubMed ID: 35587827
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Performance of machine learning algorithms for glioma segmentation of brain MRI: a systematic literature review and meta-analysis.
    van Kempen EJ; Post M; Mannil M; Witkam RL; Ter Laan M; Patel A; Meijer FJA; Henssen D
    Eur Radiol; 2021 Dec; 31(12):9638-9653. PubMed ID: 34019128
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients.
    Liu Z; Zhang W; Cheng X; Wang H; Bian L; Wang J; Han Z; Wang Y; Lian X; Liu B; Ren Z; Zhang B; Jiang Z; Lin Z; Gao Y
    Mol Med; 2021 May; 27(1):52. PubMed ID: 34051735
    [TBL] [Abstract][Full Text] [Related]  

  • 105. The efficacy of stereotactic radiotherapy followed by bevacizumab and temozolomide in the treatment of recurrent glioblastoma: a case report.
    Zhong W; Mao J; Wu D; Peng J; Ye W
    Front Pharmacol; 2024; 15():1401000. PubMed ID: 39295944
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Molecular Determinants for Photodynamic Therapy Resistance and Improved Photosensitizer Delivery in Glioma.
    Aebisher D; Woźnicki P; Czarnecka-Czapczyńska M; Dynarowicz K; Szliszka E; Kawczyk-Krupka A; Bartusik-Aebisher D
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201395
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) rs2071559 Gene Polymorphism and the Risk of Gliomas: A Systematic Review and Meta-Analysis.
    Prasetiyo PD; Wahjoepramono EJ
    J Clin Med; 2024 Jul; 13(15):. PubMed ID: 39124599
    [TBL] [Abstract][Full Text] [Related]  

  • 108. The spectrum of microvascular patterns in adult diffuse glioma and their correlation with tumor grade.
    Soni ; Walke V; Joshi D; Sharma T; Shrivastava A; Agrawal A
    J Pathol Transl Med; 2024 May; 58(3):127-133. PubMed ID: 38766738
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Biomarkers for prognosis of meningioma patients: A systematic review and meta-analysis.
    Aung TM; Ngamjarus C; Proungvitaya T; Saengboonmee C; Proungvitaya S
    PLoS One; 2024; 19(5):e0303337. PubMed ID: 38758750
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Changes in the Concentrations of Proangiogenic Cytokines in Human Brain Glioma and Acute Lymphoblastic Leukemia.
    Oldak L; Zielinska Z; Milewska P; Chludzinska-Kasperuk S; Latoch E; Konończuk K; Krawczuk-Rybak M; Starosz A; Grubczak K; Reszeć J; Gorodkiewicz E
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473833
    [TBL] [Abstract][Full Text] [Related]  

  • 111. TRIM56: a promising prognostic immune biomarker for glioma revealed by pan-cancer and single-cell analysis.
    Wang B; Wang Z; Li Y; Shang Z; Liu Z; Fan H; Zhan R; Xin T
    Front Immunol; 2024; 15():1327898. PubMed ID: 38348047
    [TBL] [Abstract][Full Text] [Related]  

  • 112. The utility of arterial spin labeling imaging for predicting prognosis after a recurrence of high-grade glioma in patients under bevacizumab treatment.
    Kambe A; Kitao S; Ochiai R; Hosoya T; Fujii S; Kurosaki M
    J Neurooncol; 2024 Jan; 166(1):175-183. PubMed ID: 38165552
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Radiogenomic Analysis of Vascular Endothelial Growth Factor in Patients With Glioblastoma.
    Zheng F; Chen B; Zhang L; Chen H; Zang Y; Chen X; Li Y
    J Comput Assist Tomogr; 2023 Nov-Dec 01; 47(6):967-972. PubMed ID: 37948373
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Micro RNAs as a Diagnostic Marker between Glioma and Primary CNS Lymphoma: A Systematic Review.
    Dabbagh Ohadi MA; Aleyasin MS; Samiee R; Bordbar S; Maroufi SF; Bayan N; Hanaei S; Smith TR
    Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509289
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Functionalized nanoparticles crossing the brain-blood barrier to target glioma cells.
    Wu Y; Qian Y; Peng W; Qi X
    PeerJ; 2023; 11():e15571. PubMed ID: 37426416
    [TBL] [Abstract][Full Text] [Related]  

  • 116. The role of lysosomal peptidases in glioma immune escape: underlying mechanisms and therapeutic strategies.
    Liu H; Peng J; Huang L; Ruan D; Li Y; Yuan F; Tu Z; Huang K; Zhu X
    Front Immunol; 2023; 14():1154146. PubMed ID: 37398678
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Use of Bevacizumab in recurrent glioblastoma: a scoping review and evidence map.
    Fu M; Zhou Z; Huang X; Chen Z; Zhang L; Zhang J; Hua W; Mao Y
    BMC Cancer; 2023 Jun; 23(1):544. PubMed ID: 37316802
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Vascular endothelial growth factor and risk of malignant brain tumor: A genetic correlation and two-sample Mendelian randomization study.
    Zhang Q; Wu G; Zhang X; Zhang J; Jiang M; Zhang Y; Ding L; Wang Y
    Front Oncol; 2023; 13():991825. PubMed ID: 36910644
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Bevacizumab as Single Agent in Children and Teenagers with Optic Pathway Glioma.
    Calò P; Pianton N; Basle A; Vasiljevic A; Barritault M; Beuriat PA; Faure-Conter C; Leblond P
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831379
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Late-line treatment with bevacizumab alone or in combination with chemotherapy in recurrent high-grade gliomas.
    Yahia-Cherif M; Luce S; De Witte O; Sadeghi-Meibodi N; Leurquin-Sterk G; Lefranc F
    Acta Neurochir (Wien); 2023 Mar; 165(3):693-699. PubMed ID: 36781461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.